Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sequential Helicobacter Pylori Eradication Therapy in Myanmar; a Randomized Clinical Trial of Efficacy and Tolerability

NCT04132479 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.

NCT NCT04132479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04132479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sequential Helicobacter Pylori Eradication Therapy in Myanmar; a Randomized Clinical Trial of Efficacy and Tolerability
Lead sponsor
Kirby Institute
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2018
Completion date
April 9, 2019
Enrollment
313 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection